The purpose of this study is to determine the safety and efficacy of sulfadoxine-pyrimethamine (SP) versus artemether-lumefantrine (Coartem) when administered to HIV+ and HIV- patients with uncomplicated P. falciparum malaria. Patients will be randomised to one of the 2 treatment and followed up (until day 14 actively) for 45 days.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
3,000
Tropical Disease Research Center
Ndola, Cupperbelt, Zambia
PCR corrected clinical and parasitological outcome at day 45
Tolerability
Clinical recovery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.